Form 4: Mannatech CFO James Clavijo Receives 10,000 Stock Options Grant

Mannatech Inc. has disclosed a grant of 10,000 stock options to its Chief Financial Officer, James Clavijo, with a vesting schedule over two years and an exercise price of $10.60 per share.

Summary

• James Clavijo, the Chief Financial Officer of Mannatech Inc. (MTEX), was granted 10,000 derivative securities in the form of stock options.
• The transaction date for this grant was June 3, 2025.
• Each option has an exercise price of $10.60 and represents the right to purchase one share of Common Stock, par value $0.0001 per share.
• The options have an expiration date of June 3, 2035.
• The vesting schedule for these options is staggered: one-third vested on the grant date (June 3, 2025), another one-third will vest on the first anniversary of the grant date (June 3, 2026), and the final one-third will vest on the second anniversary of the grant date (June 3, 2027).
• A special condition allows for immediate vesting of all options in the event of a change in control of the company.
• Following this transaction, James Clavijo beneficially owns 14,500 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine compensation disclosure that aligns management incentives with shareholder interests, which is generally viewed favorably, but it does not indicate any new operational or financial performance.

Positives

• The stock option grant aligns the Chief Financial Officer's interests with those of shareholders, as the value of the options increases with the company's stock price.
• The multi-year vesting schedule acts as a retention incentive for a key executive.

Negatives

• The exercise of these options in the future could lead to a minor dilution of existing shares, though this is a standard aspect of equity compensation plans.

Future Outlook

The document indicates a future vesting schedule for the granted stock options, with portions vesting on the first and second anniversaries of the grant date, and immediate vesting upon a change in control.

Industry Context

This Form 4 filing is a routine disclosure of executive compensation in the form of equity, a common practice across various industries to incentivize and retain key management personnel by aligning their financial interests with company performance.

Comparison to Industry Standards

• The grant of stock options to a Chief Financial Officer is a standard component of executive compensation packages across publicly traded companies, aiming to align executive incentives with shareholder value creation.
• The multi-year vesting schedule is typical for equity grants, promoting long-term retention and performance focus, consistent with practices observed in companies like Apple (AAPL) or Microsoft (MSFT) for their executive equity awards, although the specific terms (e.g., percentage vesting per year) can vary.

Related Party Transactions

• The grant of 10,000 stock options to James Clavijo, the Chief Financial Officer, constitutes a related party transaction as it involves compensation to a key management personnel.

Stakeholder Impact

• Shareholders: Potential for minor future dilution if options are exercised, but also benefit from increased alignment of executive incentives with company performance.
• Employees (specifically the CFO): Direct impact on compensation and long-term financial incentives.

Next Steps

• The remaining two-thirds of the stock options will vest on June 3, 2026, and June 3, 2027, respectively.
• The options will expire on June 3, 2035, if not exercised.

Key Dates

Keywords

Mannatech Inc., MTEX, Stock Options, Equity Compensation, Insider Transaction, Form 4, Chief Financial Officer, Executive Compensation, Vesting Schedule